What is the typical dosage and use of Famotidine (Histamine-2 (H2) blocker) for treating gastroesophageal reflux disease (GERD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Famotidine is typically prescribed at 1 mg/kg/d, divided in 2 doses, for the treatment of gastroesophageal reflux disease (GERD) in pediatric patients aged 1-16 years. The dosage of Famotidine for treating GERD can vary depending on the patient's age and weight. According to the study published in Pediatrics 1, the recommended dosage of Famotidine for pediatric patients is 1 mg/kg/d, divided in 2 doses. Some key points to consider when prescribing Famotidine for GERD include:

  • The medication should be taken 2 times a day
  • The acid-inhibiting effects of H2RAs, such as Famotidine, last for approximately 6 hours
  • H2RAs can develop a fairly rapid tachyphylaxis within 6 weeks of initiation of treatment, limiting its potential for long-term use 1
  • H2RAs have been shown to be less effective than PPIs in symptom relief and healing rates of erosive esophagitis 1 It's essential to weigh the benefits and limitations of Famotidine when treating GERD, especially considering its potential for tachyphylaxis and comparative effectiveness to other treatments like PPIs. Famotidine works by reducing stomach acid production by blocking histamine H2 receptors on the stomach's acid-producing cells, which helps alleviate GERD symptoms such as heartburn, regurgitation, and chest pain. Patients should take Famotidine as directed, and it's crucial to complete the full prescribed course even if symptoms improve quickly. Common side effects of Famotidine include headache, dizziness, and constipation, though it is generally well-tolerated 1.

From the FDA Drug Label

The use of Famotidine 20 mg and 40 mg tablets is not recommended for use in pediatric patients weighing less than 40 kg because the lowest available strength (20 mg) exceeds the recommended dose for these patients Symptomatic non-erosive GERD 20mg twice daily Up to 6 weeks Erosive esophagitis diagnosed by endoscopy 20mg twice daily; or 40mg twice daily Up to 12 weeks

The typical dosage of Famotidine for treating gastroesophageal reflux disease (GERD) is:

  • Symptomatic non-erosive GERD: 20mg twice daily for up to 6 weeks
  • Erosive esophagitis: 20mg twice daily or 40mg twice daily for up to 12 weeks 2

From the Research

Typical Dosage of Famotidine for GERD

  • The typical dosage of Famotidine for treating gastroesophageal reflux disease (GERD) is 20 mg twice daily 3, 4.
  • This dosage has been shown to be effective in relieving symptoms of GERD, including heartburn and regurgitation, and in healing erosions and ulcerations in the esophagus 4.
  • Famotidine 20 mg twice daily has also been compared to other H2-receptor antagonists, such as ranitidine, and has been found to be effective in patients who are resistant to ranitidine 5.

Use of Famotidine for GERD

  • Famotidine is a potent and long-acting H2-receptor antagonist that has been evaluated in patients with GERD 5.
  • It has been found to be effective in achieving adequate results in patients with GERD, including those with erosive reflux esophagitis 5.
  • Famotidine has also been found to be effective in preventing recurrence in most patients with healed reflux esophagitis 5.
  • The use of Famotidine for GERD is supported by studies that have shown its efficacy and safety in relieving symptoms and healing erosions and ulcerations in the esophagus 3, 4.

Comparison to Other Treatments

  • Famotidine has been compared to other treatments for GERD, including proton pump inhibitors (PPIs) 6.
  • While PPIs are commonly used to treat GERD, Famotidine may be a useful alternative for patients who do not respond to PPIs or who have certain side effects 6.
  • The choice of treatment for GERD should be based on the individual patient's needs and medical history, and should be guided by evidence-based guidelines 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.